Episodes

ClinPharmPod: COVID-19 Vaccine Hesitancy and Sociodemographics

July 9, 2021

For this episode of ClinPharmPod, host Alaina Webster sits down with Dr. Don Willis, Assistant Professor at the University of Arkansas for Medical Sciences, and moderator Dr. Erica Woodahl, Professor at the University of Montana and Associate Editor for Clinical and Translational Science (CTS). They discuss Don and his colleagues’ recent publication in CTS, “COVID-19 vaccine hesitancy: Race/ethnicity, trust, and fear,” digging into how location, race, past racism, and current systemic racism factor into the willingness to receive a COVID-19 vaccination.

ClinPharmPod

ClinPharmPod: COVID-19 Vaccine Hesitancy and Sociodemographics

00:00 / 19:18

PSPod: Journal Submissions in the Time of COVID

September 30, 2020

On the latest episode of PSPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics & Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and Shirley K. Seo, PhD, Associate Editor of Clinical Pharmacology & Therapeutics, to discuss their experiences of how COVID-19 has affected submissions and peer review for the ASCPT Family of Journals. Brian Coughlin, Publisher at Wiley, serves as moderator for the discussion.

PSPod

PSPod: Journal Submissions in the Time of COVID

00:00 / 17:28

ClinPharmPod: Journal Submissions in the Time of COVID

September 30, 2020

On the latest episode of ClinPharmPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics & Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and Shirley K. Seo, PhD, Associate Editor of Clinical Pharmacology & Therapeutics, to discuss their experiences of how COVID-19 has affected submissions and peer review for the ASCPT Family of Journals. Brian Coughlin, Publisher at Wiley, serves as moderator for the discussion.

ClinPharmPod

ClinPharmPod: Journal Submissions in the Time of COVID

00:00 / 17:13

A Holistic and Integrative Approach for Advancing Model‐Informed Drug Development

May 13, 2019

On this episode of PSPod, Dr. Rajanikanth Madabushi from the US Food and Drug Administration continues our recent discussion on model-informed drug development (MIDD) and its role in the successful implementation of PDUFA VI. This discussion is based on his co-authored Perspective article (with Drs. Yaning Wang and Issam Zineh) “A Holistic and Integrative Approach for Advancing Model‐Informed Drug Development” which published in the January 2019 issue of PSP. The article is available here.

PSPod

A Holistic and Integrative Approach for Advancing Model‐Informed Drug Development

00:00 / 11:34

PDUFA VI: It Is Time to Unleash the Full Potential of Model-Informed Drug Development with Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck

April 29, 2019

On this episode of PSPod, Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck discuss the important role model-informed drug development (MIDD) will play in the successful implementation of PDUFA VI. This discussion is based on their Perspective article “PDUFA VI: It’s Time to Unleash the Full Potential of Model-Informed Drug Development” which published in the January 2019 issue of PSP. The article is available here.

PSPod

PDUFA VI: It Is Time to Unleash the Full Potential of Model-Informed Drug Development with Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck

00:00 / 19:45